Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR ...

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Bengaluru: HealthCare Global Enterprises (HCG), one of Bengaluru’s leading cancer treatment hospitals, has come under serious ...

The Health Secretary’s 10-year plan includes proposals to bring down the cost of weight-loss drugs so more patients can get ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Procedure was performed on 54-yr-old patient from Jharkhand suffering from advanced osteoarthritis and severe knee ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr.

The invention of insulin in 1922 marked a turning point in medical history. Sparked by Frederick Bantings idea and tested on ...